JYSB2100074 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-03-12 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-03-12 | view |
JYSB2100003 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-01-07 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-01-06 | view |
JYSB2100002 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-01-07 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-01-06 | view |
JYSB2000584 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-11-28 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-11-27 | view |
JYSB2000583 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-11-28 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-11-27 | view |
JYSB2000581 | 乌司奴单抗注射液(静脉输注) | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-11-28 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-11-27 | view |
JYSB2000533 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-10-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-12-28 | view |
JYSB2000532 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-10-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-12-28 | view |
JYSB2000531 | 乌司奴单抗注射液(静脉输注) | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-10-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-12-28 | view |
JYSB2000519 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-10-16 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-11-23 | view |
JYSB2000518 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-10-16 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-11-23 | view |
JYSB2000513 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-10-13 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-10-21 | view |
JYSB2000490 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-09-30 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-10-30 | view |
JYSB2000489 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-09-30 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-10-30 | view |
JYSB2000488 | 乌司奴单抗注射液(静脉输注) | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-09-30 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-10-30 | view |
JYSB2000420 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-08-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-08-26 | view |
JYSB2000306 | 乌司奴单抗注射液(静脉输注) | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-09-14 | view |
JYSB2000305 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-09-14 | view |
JYSB2000303 | 乌司奴单抗注射液 | ustekinumab | Injection | Biological Products | Supplementary Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-09-14 | view |
JYSB2000286 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-06-19 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-06-23 | view |